Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | COCO | Common Stock | Options Exercise | $120K | +18.7K | +15.76% | $6.42* | 137K | Aug 17, 2022 | Direct | |
transaction | COCO | Common Stock | Sale | -$286K | -18.7K | -13.62% | $15.31 | 118K | Aug 17, 2022 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | COCO | Stock Option (Right to Buy) | Options Exercise | $0 | -18.7K | -100% | $0.00* | 0 | Aug 17, 2022 | Common Stock | 18.7K | $6.42 | Direct | F3 |
holding | COCO | Stock Option (Right to Buy) | 43K | Aug 17, 2022 | Common Stock | 43K | $15.36 | Direct | F4 | |||||
holding | COCO | Stock Option (Right to Buy) | 130K | Aug 17, 2022 | Common Stock | 130K | $10.18 | Direct | F5 | |||||
holding | COCO | Stock Option (Right to Buy) | 114K | Aug 17, 2022 | Common Stock | 114K | $10.18 | Direct | F6 | |||||
holding | COCO | Stock Option (Right to Buy) | 27.3K | Aug 17, 2022 | Common Stock | 27.3K | $10.18 | Direct | F7 | |||||
holding | COCO | Stock Option (Right to Buy) | 45.6K | Aug 17, 2022 | Common Stock | 45.6K | $15.00 | Direct | F8 |
Id | Content |
---|---|
F1 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.21 to $15.48, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. |
F2 | These shares consist of: (i) 66,927 unvested restricted stock units and (ii) 51,406 shares of common stock obtained from option exercises. |
F3 | The stock option is fully vested and currently exercisable |
F4 | The Reporting Person was granted stock options that will vest in three equal annual installments beginning on August 15, 2025. |
F5 | The stock option is fully vested and currently exercisable. |
F6 | The stock option is fully vested and currently exercisable with respect to 56,875 underlying shares. The remainder will vest on February 10, 2024. |
F7 | The stock option vests in two equal biennial installment beginning on January 11, 2023. |
F8 | The stock option vests in four equal annual installments beginning on November 27, 2022. |